Status:
COMPLETED
Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborating Sponsors:
Ministry of Health and Population, Malawi
Conditions:
Malaria, Falciparum
HIV Infections
Eligibility:
FEMALE
15+ years
Phase:
NA
Brief Summary
In Malawi, the standard of care to prevent malaria during pregnancy at the time of the study was a two dose sulfadoxine-pyrimethamine intermittent protective treatment (SP IPT) regimen administered in...
Detailed Description
In this protocol the researchers wish to elaborate prior investigations on factors which may affect prevalence and malarial parasite density in pregnant women in Malawi. Primarily, this investigation ...
Eligibility Criteria
Inclusion
- First or second pregnancy
- Greater than 16 weeks gestation
- Less than 28 weeks gestation
- Consent for HIV testing
Exclusion
- Less than 15 years old
Key Trial Info
Start Date :
October 1 2002
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT00126906
Start Date
October 1 2002
End Date
March 1 2005
Last Update
August 23 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Machinga District Hospital
Liwonde, Malawi